Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC. Chang JY, Verma V, Welsh JW, Formenti SC, et al. Lancet Oncol 2022;23:e156.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang JY, Verma V, Welsh JW, Formenti SC, et al. Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC. Lancet Oncol 2022;23:e156.
PMID: 35358456